DK1263790T3 - Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse - Google Patents

Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse

Info

Publication number
DK1263790T3
DK1263790T3 DK01912086T DK01912086T DK1263790T3 DK 1263790 T3 DK1263790 T3 DK 1263790T3 DK 01912086 T DK01912086 T DK 01912086T DK 01912086 T DK01912086 T DK 01912086T DK 1263790 T3 DK1263790 T3 DK 1263790T3
Authority
DK
Denmark
Prior art keywords
production method
monoclonal antibodies
ldl receptor
human ldl
human
Prior art date
Application number
DK01912086T
Other languages
Danish (da)
English (en)
Inventor
Moshe Smolarsky
Francesco Antonetti
Michel Dreano
Nachum Yonah
Dany Suissa
Ilana Belzer
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1263790(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1263790T3 publication Critical patent/DK1263790T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01912086T 2000-03-13 2001-03-08 Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse DK1263790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
DK1263790T3 true DK1263790T3 (da) 2007-07-02

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01912086T DK1263790T3 (da) 2000-03-13 2001-03-08 Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse

Country Status (32)

Country Link
US (1) US6849720B2 (de)
EP (1) EP1263790B1 (de)
JP (1) JP4768193B2 (de)
KR (1) KR100882081B1 (de)
CN (1) CN1418225B (de)
AR (1) AR028518A1 (de)
AT (1) ATE362490T1 (de)
AU (2) AU2001241002B8 (de)
BG (1) BG65762B1 (de)
BR (1) BR0109164A (de)
CA (1) CA2402593C (de)
CY (1) CY1108020T1 (de)
CZ (1) CZ20023098A3 (de)
DE (1) DE60128452T2 (de)
DK (1) DK1263790T3 (de)
EA (1) EA007494B1 (de)
EE (1) EE200200517A (de)
ES (1) ES2282238T3 (de)
HR (1) HRP20020704B1 (de)
HU (1) HU226194B1 (de)
IL (2) IL139217A0 (de)
MX (1) MXPA02009091A (de)
NO (1) NO330904B1 (de)
NZ (1) NZ520944A (de)
PL (1) PL206041B1 (de)
PT (1) PT1263790E (de)
RS (1) RS51406B (de)
SI (1) SI1263790T1 (de)
SK (1) SK287348B6 (de)
UA (1) UA78489C2 (de)
WO (1) WO2001068710A1 (de)
ZA (1) ZA200206654B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
JP5133561B2 (ja) 2003-06-19 2013-01-30 メルク セローノ ソシエテ アノニム プリオン変換を調節する因子の使用
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
JP2009526991A (ja) * 2006-02-17 2009-07-23 パオロ・ラ・コッラ 増殖性疾患及び／又はコンホメーション病の診断方法
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
NO330904B1 (no) 2011-08-15
HUP0300142A3 (en) 2005-07-28
EP1263790A1 (de) 2002-12-11
NO20024223D0 (no) 2002-09-04
NZ520944A (en) 2004-04-30
KR100882081B1 (ko) 2009-02-10
HK1055750A1 (en) 2004-01-21
YU68602A (sh) 2006-03-03
CA2402593C (en) 2012-07-03
CN1418225B (zh) 2012-04-18
NO20024223L (no) 2002-10-24
ATE362490T1 (de) 2007-06-15
MXPA02009091A (es) 2005-06-20
RS51406B (sr) 2011-02-28
AU4100201A (en) 2001-09-24
PT1263790E (pt) 2007-06-01
IL139217A0 (en) 2001-11-25
EP1263790B1 (de) 2007-05-16
EE200200517A (et) 2004-02-16
IL151713A0 (en) 2003-04-10
US20030186343A1 (en) 2003-10-02
CN1418225A (zh) 2003-05-14
BG107063A (bg) 2003-05-30
US6849720B2 (en) 2005-02-01
BR0109164A (pt) 2002-11-26
AU2001241002B8 (en) 2006-05-04
JP4768193B2 (ja) 2011-09-07
SK13122002A3 (sk) 2003-04-01
CY1108020T1 (el) 2013-09-04
SK287348B6 (sk) 2010-08-09
WO2001068710A1 (en) 2001-09-20
AU2001241002B2 (en) 2006-04-06
HU226194B1 (hu) 2008-06-30
KR20020089384A (ko) 2002-11-29
UA78489C2 (en) 2007-04-10
EA007494B1 (ru) 2006-10-27
JP2004506603A (ja) 2004-03-04
EA200200974A1 (ru) 2003-02-27
HUP0300142A2 (hu) 2003-06-28
PL358381A1 (en) 2004-08-09
AR028518A1 (es) 2003-05-14
BG65762B1 (bg) 2009-10-30
DE60128452T2 (de) 2007-09-13
DE60128452D1 (de) 2007-06-28
HRP20020704B1 (en) 2011-01-31
ZA200206654B (en) 2003-10-20
CZ20023098A3 (cs) 2003-02-12
PL206041B1 (pl) 2010-06-30
HRP20020704A2 (en) 2004-12-31
SI1263790T1 (sl) 2007-10-31
ES2282238T3 (es) 2007-10-16
CA2402593A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DK2168984T3 (da) Humane antistoffer, som binder humant IL-12, og fremgangsmåder til pro-duktion heraf
LTC2305817I2 (lt) Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas
AU2002359851A8 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
DK1432735T3 (da) Antagonistiske humane anti-htnfsf13b-antistoffer
DE60141855D1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
NO20031642D0 (no) Humaniserte anti-LT-O-R-antistoff
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
NL1026829A1 (nl) Gemodificeerde humane IGF-1R-antilichamen.
NO20032542D0 (no) Dempede anti-CD28-antistoffer og anvendelse derav
IL152725A0 (en) Human receptor proteins, related reagents and methods
NO20040249L (no) Blodgruppeantigenfusjonspolypeptider og fremgangsmater for deres anvendelse
FI20002875L (fi) Menetelmä linkkiadaptaation suorittamiseksi
NO20024223D0 (no) Monoklane antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse
EE200300569A (et) CD44v6-spetsiifilised antikehad
FI20011055L (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
ITPD20000192A0 (it) Anticorpi policlonali
EE200300377A (et) Loomulikud HI-viiruse vastased antikehad
DK1503799T3 (da) Immunogent, monoklonalt antistof
AR028262A1 (es) Anticuerpos especificos de fap-alfa humanos
IL135025A0 (en) Monoclonal antibodies to the human ldl receptor, their production and use
GB0016824D0 (en) Human monoclonal antibodies
GB0017139D0 (en) Human monoclonal antibodies